Quick Answer
SOLESENCE, INC. reported R&D Expense of $4.09 million for fiscal year 2025.
SOLESENCE, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $4.09M | +6.6% |
| 2024 | $3.84M | +0.0% |
| 2023 | $3.84M | +26.3% |
| 2022 | $3.04M | +35.9% |
| 2021 | $2.23M | +42.3% |
| 2020 | $1.57M | -16.0% |
| 2019 | $1.87M | -9.1% |
| 2018 | $2.06M | +18.5% |
| 2017 | $1.74M | +11.7% |
| 2016 | $1.55M | +22.1% |
| 2015 | $1.27M | -4.9% |
| 2014 | $1.34M | -20.3% |
| 2013 | $1.68M | +3.2% |
| 2012 | $1.63M | -6.3% |
| 2011 | $1.74M | +7.6% |
| 2010 | $1.61M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.08M | +11.5% | +13.3% |
| June 30, 2025 | $955.0K | +10.5% | -6.2% |
| March 31, 2025 | $1.02M | +11.9% | +4.9% |
| September 30, 2024 | $970.0K | -8.2% | +12.3% |
| June 30, 2024 | $864.0K | -12.8% | -5.1% |
| March 31, 2024 | $910.0K | -9.3% | -13.9% |
| September 30, 2023 | $1.06M | +24.6% | +6.7% |
| June 30, 2023 | $991.0K | +24.3% | -1.2% |
- SOLESENCE, INC. showed an increase of +6.6% in R&D Expense compared to the prior fiscal year.
- Over the 2010–2025 period, SOLESENCE, INC.’s r&d expense has grown by 153.3% (from $1.61 million to $4.09 million).
- The most recent figure is from SOLESENCE, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: